Before announcing what became a highly controversial merger, Hewlett-Packard Inc. and Compaq Corp. prepared themselves for an onslaught by installing a favorite protective measure. Each enacted a poison pill that took on the unusual guise of promoting a deal. Installation of shareholders rights plans has gained popularity among some merger-bound companies. The pill is designed to discourage competing bidders from trying to swipe one of the partners while the sometimes-lengthy merger process unfolds. Among the other companies voting in pills during September were: Anchor Glass Container; Art Technology Group; BEA Systems; BindView; California Micro Devices; Collateral Therapeutics; Del Global Technologies; Fibrestars; First Leesport Bancorp; G&K Services; GenVec; MarineMax; Select Medical; U.S. Energy; and Unique Broadband Systems.
Intelligence for the Dealmaking Community since 1965
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
